Email Address
Password
List of Document Downloads
NVCA Statement Regarding Medical Device Safety Act, May 9, 2009
NVCA White Paper: Innovation & Comparative Effectiveness Research Priorities
NVCA 2009 Annual Meeting Lifesciences Track Presentations
Materials from NVCA Medical Industry Group Meeting, April 2009
Investing in Personalized Health Care Innovation (White Paper) - September, 2008
NVCA's Healthcare Reform Principles - September, 2008
Patent Reform - June, 2008
Abbreviated FDA Approval Pathway for Follow-on Biologics (FOBs) - June, 2008
Government Regulation Impacting the Development of Medical Innovation, FDA and CMS Process Reform- June, 2008
NVCA Letter on HR5629 - Pathway Biosimilar Act - May 16, 2008
NVCA Letter on Follow-on Biologics - May 2, 2008
NVCA Congressional Testimony on SBIR Reauthorization - March 13, 2008
Presentation: President’s Council of Advisors on Science and Technology, Personalized Medicine Subcommittee - January 9, 2008
NVCA Letter to Senators Leahy and Specter on Patent Reform - November 6, 2007
Patent Reform Position Paper - Updated Oct. 2007
House Small Business Committee Hearing - Patent Reform Impact on Small Venture-backed Companies (March 29, 2007)
Proposal for a Reimbursement "Critical Path" for CMS
Substantial Clinical Improvement Requirement for New Technology Add-On Payments
NVCA Comments on Coverage with Evidence Development Guidance
NVCA White Paper on the Future of Government Innovation
